Kyverna Therapeutics (KYTX) Change in Acquisitions & Divestments (2023 - 2026)

Kyverna Therapeutics (KYTX) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $65.7 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 24.22% year-over-year to $65.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $384.7 million (down 2.61% YoY) and the FY2025 annual result came in at $405.7 million, up 22.46% from the prior year.
• Change in Acquisitions & Divestments slipped to $65.7 million in Q1 2026, from $99.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $157.0 million in Q4 2024 to a low of $13.0 million in Q2 2024.
• A 4-year average of $77.2 million and a median of $86.7 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• The widest YoY moves for Change in Acquisitions & Divestments: up 854.62% in 2025, down 36.81% in 2025.
• Tracing KYTX's Change in Acquisitions & Divestments over 4 years: stood at $33.0 million in 2023, then jumped by 375.76% to $157.0 million in 2024, then plunged by 36.81% to $99.2 million in 2025, then slumped by 33.77% to $65.7 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $65.7 million (Q1 2026), $99.2 million (Q4 2025), and $95.7 million (Q3 2025), per Business Quant data.